Molecular therapy for Human Cancer: Suppressor of cytokine signaling 1 (SOCS1) suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 3/May/2015, 7.53 am

Regenerating the lost cardiomyocytes in Myocardial patients: FRA1 increases the expression of ERBB2 and promotes dedifferentiation of cardiomyocytes via down regulation of its target gene, 3/May/2014, 12.39 am
May 2, 2015
Natural product-based therapy for pulmonary diabetic cardiomyopathy: Agaricus blazei Murill (AbM), a medicinal mushroom, inhibits the development of diabetic cardiomyopathy via down regulation of its target gene Foxo1, 3/May/2015, 09.19 am
May 3, 2015
Show all

The 1989 Noble prize winner in Chemistry, Prof. Thomas R. Cech, from the University of Colorado BioFrontiers Institute, USA, has published a research paper in the 13 December 2012 Nature (492(7428):285-9; and I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity.”  This study provides mechanistic insights into how TPP1 regulates telomerase function.

In connection with this finding, Dr Boominathan, Founder Director-cum-chief scientist of GBMD, reports that: Molecular therapy for Human Cancer: Suppressor of cytokine signaling 1 (SOCS1) suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene Remarkably, over 90% human tumors over express telomerase, suggesting that inhibition of its activity may increase the efficacy of anticancer therapy.  Together, this study suggests that pharmacological formulations containing “SOCS1 activators” can be used in the treatment of human cancers.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,   Molecular therapy for Human Cancer: Suppressor of cytokine signaling 1 (SOCS1) suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via up regulation of its target gene, 3/May/2015, 7.53 am,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How SOCS1 suppresses the expression of TPP1

Comments are closed.